Composition:
BUTRUM Injection contains Butorphanol Tartrate equivalent to Butorphanol 1 mg per injection, formulated in a sterile aqueous solution for parenteral administration.
Description:
BUTRUM is an opioid analgesic used for the management of moderate to severe pain. It acts as a mixed agonist–antagonist opioid, providing effective analgesia while reducing the risk of certain opioid-related adverse effects. It is commonly used in postoperative pain, preoperative medication, obstetric analgesia, and for pain control in acute clinical settings. The injection offers rapid onset of action when administered intravenously or intramuscularly under medical supervision.
Precautions:
The injection should be administered only by a healthcare professional. Use with caution in patients with respiratory disorders, head injury, liver or kidney impairment, and in those with a history of substance dependence. Concomitant use with other central nervous system depressants such as sedatives, alcohol, or anesthetics may enhance respiratory and CNS depression. Dose adjustment may be required in elderly patients. Not recommended during pregnancy and breastfeeding unless clearly advised by a physician.
Adverse Effects:
Common adverse effects may include drowsiness, dizziness, nausea, vomiting, sweating, dry mouth, and headache. Some patients may experience respiratory depression, sedation, hypotension, or confusion. Rarely, allergic reactions such as rash or hypersensitivity may occur.
Storage:
Store in a cool, dry place below 25°C and protect from light. Do not freeze. Keep the ampoule/vial in its original packaging until use and out of reach of children.
